首页 › 基金 › Ensign Peak Advisors, Inc › BSX
Ensign Peak Advisors, Inc 对 BSX 的持仓历史
BOSTON SCIENTIFIC CORP · 医疗保健
Ensign Peak Advisors, Inc 在 Q2 2026 的 13F 申报中披露持有 BSX(BOSTON SCIENTIFIC CORP)5,881,367 股,市值约 US$251.0M,约占其申报组合的 0.41%,在其申报持仓中市值排名第 44 位。 Ensign Peak Advisors, Inc 最近 12 个申报季度中有 12 个季度披露了 BSX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Ensign Peak Advisors, Inc 对 BSX 的持仓演变
Ensign Peak Advisors, Inc 于 Q3 2023 首次披露 BSX 持仓:1,858,961 股(约 US$98.2M)。 该持仓在 Q1 2026 达到峰值 4,507,242 股,市值约 US$282.8M。 在 12 次申报中,Ensign Peak Advisors, Inc 7 次增持、4 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 5,881,367 股、市值约 US$251.0M,环比增持 1,374,125 股。。 持仓曾出现大幅变动:Q1 2025 减持约 37% (随后一个季度股价上涨 6%)、Q1 2026 增持约 186% (随后一个季度股价下跌 32%)、Q2 2026 增持约 30% (随后一个季度股价上涨 2%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 1.86M | $98.15M | 新进 |
| Q4 2023 | 1.93M | $111.79M | 增持 |
| Q1 2024 | 2.23M | $152.58M | 增持 |
| Q2 2024 | 1.85M | $142.27M | 减持 |
| Q3 2024 | 1.68M | $141.04M | 减持 |
| Q4 2024 | 1.54M | $137.19M | 减持 |
| Q1 2025 | 974.16K | $98.27M | 减持 |
| Q2 2025 | 1.25M | $134.42M | 增持 |
| Q3 2025 | 1.48M | $144.05M | 增持 |
| Q4 2025 | 1.58M | $150.44M | 增持 |
| Q1 2026 | 4.51M | $282.83M | 增持 |
| Q2 2026 | 5.88M | $251.02M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BSX 与 13F 数据
BSX(BOSTON SCIENTIFIC CORP)属于医疗保健行业。我们追踪的基金中还有 20 只申报持有 BSX,申报仓位最大的包括:Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), 德劭基金 (US$1.16B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BSX 的基金
- Banque Cantonale Vaudoise 67.61K 股 · $2.89B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 50.52M 股 · $2.16B · Q2 2026
- 德劭基金 27.27M 股 · $1.16B · Q2 2026
- 骏利亨德森集团 16.50M 股 · $1.04B · Q1 2026
- Arrowstreet 资本 23.29M 股 · $994.18M · Q2 2026
- Bollard Group LLC 18.42M 股 · $786.20M · Q2 2026
更多关于 Ensign Peak Advisors, Inc
常见问题
How long has Ensign Peak Advisors, Inc held BSX?
Ensign Peak Advisors, Inc has disclosed BSX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Ensign Peak Advisors, Inc's current position in BSX?
As of Q2 2026, Ensign Peak Advisors, Inc holds 5.88M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $251.02M, representing 0.41% of its reported portfolio and ranking #44.
Has Ensign Peak Advisors, Inc been buying or selling BSX?
In the latest 13F filing (Q2 2026), Ensign Peak Advisors, Inc increased its position in BSX. The position peaked in Q1 2026 at 4.51M shares.
Which other funds hold BSX?
Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, 德劭基金, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.